Comment: mibefradil, a new class of calcium-channel antagonists.
Otterman
S
S
D001562:Benzimidazoles / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D020748:Mibefradil; D013764:Tetrahydronaphthalenes / Q000009:adverse effects*
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil; D003577:Cytochrome P-450 Enzyme System